Loading term…
The EMA committee responsible for assessing and monitoring safety issues for human medicines, including signal assessment and risk management recommendations.
PRAC reviews signals detected in EudraVigilance, assesses PSUR findings, and makes recommendations that may lead to label changes, restrictions, or withdrawals.
EU Regulation 726/2004
Not adequately preparing for or responding to PRAC requests for information or assessment reports.
How do you prepare for PRAC signal assessments? Describe your interaction with PRAC.